Variant report
Variant | esv3426994 |
---|---|
Chromosome Location | chr2:56615848-56617796 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146851153 | chr2:56615861-56615862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527792993 | chr2:56615874-56615875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190932928 | chr2:56615915-56615916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs28534795 | chr2:56615946-56615947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576568870 | chr2:56615962-56615963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183390230 | chr2:56615967-56615968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187467862 | chr2:56615979-56615980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192696993 | chr2:56615980-56615981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139226122 | chr2:56615998-56615999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576957260 | chr2:56616031-56616032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565722129 | chr2:56616038-56616039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546151762 | chr2:56616058-56616059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559664335 | chr2:56616084-56616085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534410951 | chr2:56616100-56616101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554286243 | chr2:56616108-56616109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs60097858 | chr2:56616122-56616123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536475306 | chr2:56616165-56616166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541862197 | chr2:56616172-56616173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs13426375 | chr2:56616204-56616205 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs2869810 | chr2:56616218-56616219 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs371554272 | chr2:56616235-56616236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184541158 | chr2:56616250-56616251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572518580 | chr2:56616252-56616253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368812391 | chr2:56616259-56616260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140932250 | chr2:56616276-56616277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541526570 | chr2:56616294-56616295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561399126 | chr2:56616301-56616302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529890011 | chr2:56616329-56616330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543270184 | chr2:56616351-56616352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563559173 | chr2:56616362-56616363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532308586 | chr2:56616372-56616373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142094392 | chr2:56616373-56616374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115990361 | chr2:56616406-56616407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528108333 | chr2:56616410-56616411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188179845 | chr2:56616443-56616444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191828366 | chr2:56616445-56616446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13426773 | chr2:56616454-56616455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536413432 | chr2:56616469-56616470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556486327 | chr2:56616486-56616487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570280904 | chr2:56616532-56616533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184220005 | chr2:56616550-56616551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564560872 | chr2:56616553-56616554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559240141 | chr2:56616554-56616555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572451783 | chr2:56616579-56616580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7606024 | chr2:56616595-56616596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569722961 | chr2:56616653-56616654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72618680 | chr2:56616697-56616698 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs574999411 | chr2:56616717-56616718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543557237 | chr2:56616754-56616755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563336372 | chr2:56616769-56616770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56612200-56617200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
2 | chr2:56617000-56619200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr2:56617600-56618200 | Enhancers | HUVEC | blood vessel |